Development of Innovative Proton and Neutron Therapies With High Cancer Specificity by ‘Hijacking’ the Intracellular Chemistry of Haem Biosynthesis
Follow us on Social Media   

About us

NuCapCure's mission is to revolutionise modern oncology through two ground-breaking treatments for the world's most common and deadliest brain tumour with no curative treatment, Glioblastoma multiforme (GBM), and thus promote the well-being of global societies. The European Innovation Council (EIC) recognised the potential of the project to deliver a visionary and disruptive innovation that could result in significant societal benefit. It has therefore funded NuCapCure as part of the Pathfinder Open Programme in Horizon Europe.

DISCOVER MORE ABOUT OUR RESEARCH

"The NuCapCure project can revolutionise cancer treatment, aiming to offer curative yet cost-effective alternatives for GBM, providing significant benefits for patients, healthcare systems, and the society as a whole." Dr Theodossis Theodossiou – Universitetet i Oslo
NuCapCure project coordinator
240KBRAIN CANCERPATIENTS GLOBALLYEACH YEAR7TOTAL OFPARTNERS3RESEARCHDISCIPLINES6 MILEUROBUDGET2NEW TREATMENTMETHODS54MONTHS OFDURATION